Mirus Advises TheraCell on its Sale to Isto Biologics 
Mirus Capital Advisors is pleased to announce that it served as the exclusive financial advisor…
paganoApril 7, 2022
Mirus Client AdvanSource Biomaterials Corporation Completes the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America
Burlington, MA – Mirus Capital Advisors announced today that it acted as the exclusive financial…
paganoFebruary 10, 2020
BIO2 TECHNOLOGIES, INC. CLOSES SERIES C EQUITY FINANCING
Mirus Capital Advisors announced today that it acted as the exclusive financial advisor to Bio2…
paganoJanuary 7, 2019
Alan Fullerton advised Biopure (Nasdaq:BPUR), a developer of oxygen therapeutics
Alan Fullerton advised Biopure (Nasdaq:BPUR), a developer of oxygen therapeutics for veterinary and human use,…
paganoFebruary 20, 2005
